Covered recipient · General Payments record
LAURIE-ANNE C SWABY
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,988.86
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $399.54 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $211.57 | 13 |
| 3-D Matrix, Inc. | $124.78 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $34.82 | 2 |
| Celgene Corporation | $28.37 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| 3-D Matrix, Inc. | $124.78 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154788339 | CMS |
| ABBVIE INC. | $27.08 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187674 | CMS |
| ABBVIE INC. | $11.62 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187676 | CMS |
| ABBVIE INC. | $16.33 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187678 | CMS |
| ABBVIE INC. | $27.29 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187680 | CMS |
| ABBVIE INC. | $25.39 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187682 | CMS |
| ABBVIE INC. | $21.79 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187684 | CMS |
| ABBVIE INC. | $19.81 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187686 | CMS |
| ABBVIE INC. | $2.89 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187688 | CMS |
| ABBVIE INC. | $6.29 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187690 | CMS |
| ABBVIE INC. | $19.31 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187692 | CMS |
| ABBVIE INC. | $17.73 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187694 | CMS |
| ABBVIE INC. | $3.34 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187696 | CMS |
| ABBVIE INC. | $12.70 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106187698 | CMS |
| Boston Scientific Corporation | $15.52 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092466383 | CMS |
| Boston Scientific Corporation | $19.30 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092466385 | CMS |
| Celgene Corporation | $14.16 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101140786 | CMS |
| Celgene Corporation | $14.21 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101140794 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.